There’s Now a $1-A-Pill Competitor to Martin Shkreli’s $750 Cancer/HIV Drug

shkrelfeat

San Diego-based Imprimis Pharmaceuticals has created an alternative drug to Daraprim, the drug used to treat HIV and cancer patients whose rights were bought by Martin Shkreli’s Turing Pharmaceuticals and subsequently raised from $13.50 per pill to $750.

The best part of Imprimis’ medication? It only costs $1. Mark L. Baum, Imprimis’ CEO, said in a news release:

“While we respect Turing’s right to charge patients and insurance companies whatever it believes is appropriate, there may be more cost-effective compounded options for medications, such as Daraprim.”

Imprimis’ new drug is very similar to Daraprim, whose main active ingredient is pyrimethamine. Imprimis’s drug contains pyrimethamine as well as leucovorin, which helps to reverse pyrimethamine’s negative effects on bone marrow. Before Imprimis’s drug, Turing Pharmaceuticals was the only source for the drug, which is used for patients with compromised immune systems due to cancer or HIV.

Imprimis’s product is their direct response to Shkreli’s seemingly unreasonable price hike on Daraprim. The company also announced that they will be producing affordable versions of 7,800 generic FDA-approved drugs under their initiative Imprimis Cares.

h/t: Arstechnica

Support our Journalism with a Contribution

Many people might not know this, but despite our large and loyal following which we are immensely grateful for, NextShark is still a small bootstrapped startup that runs on no outside funding or loans.

Everything you see today is built on the backs of warriors who have sacrificed opportunities to help give Asians all over the world a bigger voice.

However, we still face many trials and tribulations in our industry, from figuring out the most sustainable business model for independent media companies to facing the current COVID-19 pandemic decimating advertising revenues across the board.

We hope you consider making a contribution so we can continue to provide you with quality content that informs, educates and inspires the Asian community. Even a $1 contribution goes a long way. Thank you for everyone’s support. We love you all and can’t appreciate you guys enough.

NextShark is a leading source covering Asian American News and Asian News including business, culture, entertainment, politics, tech and lifestyle.

For advertising and inquiries: info@nextshark.com